Creative Bioarray Develops State-of-the-art Chromosome Analysis to Support the Research of Molecular Biology and Histopathology – Digital Journal

Creative Bioarray has extensive expertise in banded chromosome analysis which include the analysis of live animals and established adult and embryonic stem cell lines to support the research of molecular biology and histopathology. New York, USA June 16, 2021 Creative Bioarray, the innovative biotechnology company focuses on developing unique technologies with high quality products and satisfactory services to accelerate life sciences research, solve complex analytical challenges and increase laboratory productivity. Creative Bioarray has extensive expertise in banded chromosome analysis which includes the analysis of live animals and established adult and embryonic stem cell lines to support the research of molecular biology and histopathology.

Read more
Orgenesis announces use of the Tissue Genesis Icellator in – GlobeNewswire

GERMANTOWN, Md., June 10, 2021 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (Orgenesis or the Company), a global biotech company working to unlock the full potential of celland gene therapies, announces that enrollment has commenced for a clinical trial using the Tissue Genesis Icellator at the Hospital for Special Surgery (HSS) in New York, NY. The phase 2, randomized, placebo-controlled trial, which is supported by the National Stem Cell Foundation and an OREF Clinical Research Grant in Cellular Therapy in Honor of James Urbaniak, MD, will evaluate safety and efficacy of autologous stromal and vascular fraction cells (SVF) that are injected after surgical rotator cuff repair.

Read more
The Canine Stem Cell Therapy Market To Witness An Exponential Satiation In The Next 10 Years The Courier – The Courier

Like all the other verticals, the healthcare vertical is poised to witness an amalgamation of collaborations and networks as a result of the culture of belonging and inclusion being the new DNA therein. Also, remote work arrangements will be simplified with shared services, cloud technologies, and AI is in place. The Canine Stem Cell Therapy Market is meant to capture these happenings and give insights regarding the same.

Read more